HEPATIC ENCEPHALOPATHY
Clinical trials for HEPATIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEPATIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for HEPATIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Antibiotic trial targets toxic brain fog in liver patients
Disease control CompletedThis study tested whether an antibiotic called nifuroxazide could safely treat brain fog (hepatic encephalopathy) in people with advanced liver disease. It involved 80 Egyptian patients hospitalized with moderate to severe symptoms. The goal was to see if the drug could clear the…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Cairo University • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New hope for restless nights in liver disease?
Symptom relief CompletedThis study tested whether a sleep medicine called lemborexant is safe and effective for people with liver cirrhosis who have trouble sleeping. It involved 82 adults with cirrhosis and poor sleep, comparing the drug to a placebo. The goal was to see if it improved sleep quality wi…
Matched conditions: HEPATIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC